Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0001-7103-373XUnclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
4 papers
Recent·Most cited
Darren Lee, Yazan Abu-Shihab, Kate Plas…·Linde A. Miles
This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.
Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno…·Koichi Takahashi
This study examines how chemotherapy affects clonal diversity and mutation patterns in hematopoietic stem cells, finding that melphalan increases mutational burden and promotes clonal aging, potentially leading to therapy-related myeloid neoplasms.
Warren C. Fiskus, Jessica C. Piel, Michael P. Collins…·Kapil N. Bhalla
This study shows that FHD-286, a BRG1/BRM inhibitor, reduces AML burden and improves survival when combined with Menin or BET inhibitors in xenograft models of AML with MLL1r or mtNPM1.